Eisai Co Eulerpool News

Eisai Co Eulerpool News

Eisai Co Aktie News

Eisai Co wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Eisai Co News stellen wir hier zusammen.

• 16. Mai ·

  SeekingAlpha
  Eisai Co Ltd. (ESALF) Q4 2024 Earnings Call Transcript
• 15. Mai ·

  Yahoo
  Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
• 30. April ·

  SeekingAlpha
  Biogen: Don't Overthink This One
• 24. April ·

  Yahoo
  Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock
• 22. April ·

  SeekingAlpha
  Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade)
• 1. April ·

  Yahoo
  Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
• 17. März ·

  SeekingAlpha
  Eisai: All About Lenvima And Leqembi
• 11. Februar ·

  SeekingAlpha
  Week In Review: I-Mab Morphs Into U.S.-Only Company, Sells China Assets For $80M
• 6. Februar ·

  SeekingAlpha
  Eisai Co Ltd (ESALF) Q3 2023 Earnings Call Transcript
• 31. Januar ·

  Yahoo
  Biogen Quits Controversial Alzheimer’s Drug Aduhelm